Findings from a large “real-world” study show the multimodal minimally invasive glaucoma surgery (MIGS) device, Hydrus Microstent (Ivantis) safely and effectively treats a wide variety of glaucoma types, providing reductions in IOP and medication burden that are durable through at least three years,
California-based manufacturer of augmented reality (AR) glasses, Ocutrx Vision Technologies, has released a new, state-of-the-art design for its flagship Oculenz AR Wear glasses.
The Independent Optometry Group (IOG) is hosting its optometry business conference, ‘Future vision – embracing disruption, building resilience’, at the Novotel in Queenstown from 14-16 June 2019.
In New Zealand, the Auckland council has made changes to its health and hygiene bylaw to ban eyeball tattooing unless it’s carried out by an ophthalmologist, while adding that all services that pierce or risk breaking or burning tissue (not just the skin) must be licensed from 1 March this year.
Optica Life Accessories has announced a new partnership with Look Sharp Eyewear, covering its optometry range of products in the New Zealand market.
Patients implanted with an iStent achieved significantly higher treatment success and were much less likely to need add-on medications five years post-operatively, compared to patients on topical
Australian scientists have found significant differences in the shape and biology of the same type of cell taken from different parts of the retina, according to a study published in eLife.The results
Early results of an ongoing clinical trial indicate implantation of a sterile allograft corneal inlay (Transform, Allotex) in the non-dominant eye is a promising option for presbyopia correction in
A new international initiative to prevent glaucoma-related vision loss in low and middle-income countries aims to do so by building local healthcare capacity. Keep Sight said its goal was to provide
A laser-based technique that can produce a full 3D image of all the layers of the retina, allowing doctors to better diagnose and treat eye diseases such as cataracts, diabetic retinopathy, and cancer
Sydney-based researcher Professor Robyn Jamieson, in collaboration with researchers in the US and the Netherlands, has identified a new syndrome slowly sending an entire Australian family blind and impacting four other families around the world.
Researchers have discovered the retina has a regenerative capacity kept dormant by a cellular signalling mechanism called the Hippo pathway, providing the possibility of one day restoring vision loss by activating the retina’s ability to regenerate.
